Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Immunocellular Thera (IMUC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,174
  • Shares Outstanding, K 41,940
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 36-Month Beta 0.94
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.34
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/18/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0200 +40.00%
on 11/26/18
0.0370 -24.32%
on 11/16/18
-0.0080 (-22.22%)
since 11/09/18
3-Month
0.0200 +40.00%
on 11/26/18
0.2550 -89.02%
on 09/25/18
-0.1920 (-87.27%)
since 09/11/18
52-Week
0.0200 +40.00%
on 11/26/18
0.5500 -94.91%
on 12/14/17
-0.2020 (-87.83%)
since 12/11/17

Most Recent Stories

More News
ImmunoCellular Announces Receipt of Notice of Noncompliance with The NYSE American Continued Listing Standards

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE American: IMUC) today announced that on October 16, 2018, the Company received notice from the NYSE American LLC ("NYSE American" or the "Exchange")...

IMUC : 0.0280 (unch)
ImmunoCellular Announces Receipt of Notice of Noncompliance with The NYSE American Continued Listing Standards

LOS ANGELES , Oct. 17, 2018 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE American: IMUC) today announced that on October 16, 2018 , the Company received notice...

IMUC : 0.0280 (unch)
ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE American: IMUC) today notified the NYSE American of its intention to voluntarily withdraw its Common Stock (NYSE American: IMUC) and Listed Common...

IMUC : 0.0280 (unch)
ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants

LOS ANGELES , Oct. 15, 2018 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE American: IMUC) today notified the NYSE American of its intention to voluntarily withdraw its...

IMUC : 0.0280 (unch)
ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE American: IMUC) today announced financial results for the first quarter ended March 31, 2018.

IMUC : 0.0280 (unch)
Analysis: Positioning to Benefit within DDR, Diamond Offshore Drilling, Energen, ImmunoCellular Therapeutics, Juniper Networks, and ServiceNow -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of DDR Corp. (NYSE:DDR), Diamond...

IMUC : 0.0280 (unch)
DDR : 11.99 (-3.07%)
JNPR : 27.83 (+0.80%)
NOW : 183.42 (-0.80%)
DO : 11.15 (-2.53%)
EGN : 72.12 (+2.11%)
ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular" or the Company) (NYSE American: IMUC) announced today that it has been able to verify successful transfer of the selected T cell receptor genetic material...

IMUC : 0.0280 (unch)
ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program

LOS ANGELES , April 12, 2018 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular" or the Company) (NYSE American: IMUC) announced today that it has been able to verify successful...

KLAC : 92.73 (+0.49%)
IMUC : 0.0280 (unch)
ImmunoCellular Therapeutics Receives Audit Opinion with Going Concern Explanation

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE American: IMUC) today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2017 filed with...

IMUC : 0.0280 (unch)
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE American: IMUC) today announced financial results for the fourth quarter and full year ended December 31, 2017.

IMUC : 0.0280 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade IMUC with:

Key Turning Points

2nd Resistance Point 0.0316
1st Resistance Point 0.0298
Last Price 0.0280
1st Support Level 0.0244
2nd Support Level 0.0208

See More

52-Week High 0.5500
Fibonacci 61.8% 0.3475
Fibonacci 50% 0.2850
Fibonacci 38.2% 0.2225
Last Price 0.0280
52-Week Low 0.0200

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar